110 results
Page 3 of 6
8-K
aczvz3 ub056fv
13 May 21
Other Events
4:19pm
8-K
EX-99.1
2c0 wanz4rjq86q2zm
30 Mar 21
Moleculin Receives FDA Approval of Fast Track
7:30am
8-K
EX-99.1
r792l56p6e8vhwkjl
8 Feb 21
Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases
7:29am
424B5
3jwkns2n8jn
4 Feb 21
Prospectus supplement for primary offering
4:01pm
424B5
cpn37gd0
2 Feb 21
Prospectus supplement for primary offering
4:29pm
8-K
EX-99.1
x1hiq60cwt78z
2 Feb 21
Moleculin Announces 100% Survival Achieved in Osteosarcoma Lung Metastases Animal Model
7:29am
8-K
EX-99.1
2u9zrv9j
1 Feb 21
Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial
7:29am
8-K
EX-3.1
r7j 8w0d6
29 Jan 21
Moleculin Announces Reverse Stock Split
9:15am
424B5
mmyfmdpbbf1imf pec0
12 Nov 20
Prospectus supplement for primary offering
4:31pm
S-8
EX-4.4
pb2npw26ez56 igv1
21 Aug 20
Registration of securities for employees
4:31pm
424B5
aon8mca79peib149jk9
17 Jul 20
Prospectus supplement for primary offering
5:16pm